Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Diamyd Medical AB (publ) (ST: DMYD-B)

 
DMYD-B Technical Analysis
2
As on 9th Jan 2026 DMYD-B STOCK Price closed @ 12.60 and we RECOMMEND Buy for LONG-TERM with Stoploss of 11.63 & Strong Sell for SHORT-TERM with Stoploss of 16.59 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

DMYD-BSTOCK Price

Open 11.92 Change Price %
High 12.64 1 Day 0.76 6.42
Low 11.78 1 Week 2.52 25.00
Close 12.60 1 Month 3.34 36.07
Volume 900755 1 Year -0.38 -2.93
52 Week High 19.08 | 52 Week Low 7.59
 
ST Sweden Most Active Stocks
ENERS 0.00 %
QUIA 0.00 %
LIPI 0.22 -4.35%
LPGO 0.02 100.00%
LUNE 21.97 6.65%
ATORX 0.49 48.48%
SBB-B 4.98 4.84%
POLY 0.04 0.00%
ACTI 0.04 0.00%
TERRNT-B 0.07 0.00%
 
ST Sweden Top Gainers Stocks
KOPY 0.10 150.00%
LPGO 0.02 100.00%
PROGEN 0.74 57.45%
ATORX 0.49 48.48%
FRAG 8.72 41.56%
SPIFF 0.04 33.33%
SOZAP 0.25 25.00%
ECC-B 0.58 18.37%
HEGR 0.63 14.55%
ELIC 5.92 13.85%
 
ST Sweden Top Losers Stocks
SECI 0.01 -50.00%
SECI 0.01 -50.00%
ZICC 0.25 -34.21%
LIDDS 0.02 -33.33%
AUR 0.82 -31.67%
AUR 0.82 -31.67%
ALLR 1.55 -26.54%
EPIS-B 0.03 -25.00%
ASAP 0.03 -25.00%
ASAP 0.03 -25.00%
 
 
DMYD-B
Daily Charts		 DMYD-B
Intraday Charts		 Whats New @
Bazaartrend		 DMYD-B
Free Analysis
 
DMYD-B Important Levels Intraday
RESISTANCE14.26
RESISTANCE13.73
RESISTANCE13.40
RESISTANCE13.07
SUPPORT12.13
SUPPORT11.80
SUPPORT11.47
SUPPORT10.94
 
DMYD-B Forecast January 2026
Share
4th UP Forecast21.27
3rd UP Forecast18.49
2nd UP Forecast16.77
1st UP Forecast15.05
1st DOWN Forecast10.15
2nd DOWN Forecast8.43
3rd DOWN Forecast6.71
4th DOWN Forecast3.93
 
DMYD-B Weekly Forecast
4th UP Forecast18.96
3rd UP Forecast16.92
2nd UP Forecast15.66
1st UP Forecast14.40
1st DOWN Forecast10.80
2nd DOWN Forecast9.54
3rd DOWN Forecast8.28
4th DOWN Forecast6.24
 
DMYD-B Forecast2026
4th UP Forecast35.72
3rd UP Forecast28.31
2nd UP Forecast23.72
1st UP Forecast19.14
1st DOWN Forecast6.06
2nd DOWN Forecast1.48
3rd DOWN Forecast-3.11
4th DOWN Forecast-10.52
 
 
DMYD-B Other Details
Segment EQ
Market Capital 1424686208.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
DMYD-B Address
DMYD-B
 
DMYD-B Latest News
 
Your Comments and Response on Diamyd Medical AB (publ)
 
DMYD-B Business Profile
Diamyd Medical AB (publ) engages in developing therapies for the treatment of autoimmune diabetes. The company develops Diamyd, an antigen-specific immunomodulating diabetes vaccine for the treatment of type 1 diabetes and latent autoimmune diabetes, which is in Phase IIb clinical development; and Remygen, an oral regenerative and immunomodulatory drug candidate for the treatment of autoimmune and type 2 diabetes, which is in Phase I/II clinical development. Diamyd Medical AB (publ) was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB (publ) in April 2013. The company was founded in 1984 and is based in Stockholm, Sweden. Address: Kungsgatan 29, Stockholm, Sweden, 111 56
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service